Current Cancer Drug Targets
(CURR CANCER DRUG TAR) 《癌症药靶研究最新进展》
2012年影响因子
4
最新一期
Editorial: [Hot Topic: New Approaches in the Treatment of Multiple Myeloma: From Target-based Agents to the New Era of microRNAs (Dedicated to the Memory of Prof. Salvatore Venuta)] Pp.741-742 |
Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium Pp.743-756 |
Molecular Targets for the Treatment of Multiple Myeloma Pp.757-767 |
Antiangiogenic Therapeutic Approaches in Multiple Myeloma Pp.768-775 |
Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma Pp.776-796 |
Novel Targets and Derived Small Molecule Inhibitors in Multiple Myeloma Pp.797-813 |
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma Pp.814-822 |
MicroRNAs in the Pathobiology of Multiple Myeloma Pp.823-837 |
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma Pp.838-846 |
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells Pp.847-856 |
A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma Pp.857-872 |
A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis Pp.873-898 |